所有图片(1)

文件

Y0000608

比沙可啶

Name: 比沙可啶
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

Bisacodyl

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₂₂H₁₉NO₄

CAS号:

603-50-9

分子量:

361.39

MDL编号:

MFCD00038039

UNSPSC代码:

41116107

PubChem化学物质编号:

329831047

NACRES:

NA.24

等级

pharmaceutical primary standard

API类

bisacodyl

制造商/商品名称

EDQM

应用

pharmaceutical (small molecule)

格式

neat

储存温度

2-8°C

SMILES字符串

CC(=O)Oc1ccc(cc1)C(c2ccc(OC(C)=O)cc2)c3ccccn3

InChI

1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3

InChI key

KHOITXIGCFIULA-UHFFFAOYSA-N

正在寻找类似产品? 访问产品对比指南

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

应用

Bisacodyl for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包装

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

1074042

1074030

4,4′-(2-Pyridinylmethylene)bisphenol, United States Pharmacopeia (USP) Reference Standard

1074051

1074073

BP047

比沙可啶, British Pharmacopoeia (BP) Reference Standard

PHR2794

比沙可啶, certified reference material, pharmaceutical secondary standard

象形图

GHS07

警示用语：

Warning

危险声明

H315,H319,H335

预防措施声明

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

危险分类

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

靶器官

Respiratory system

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.

J Tack et al.

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 27(3), 397-405 (2015-01-13)

Prucalopride is a high-affinity 5-HT4 receptor agonist for the treatment of chronic constipation. The aims of this study were to investigate the relationship between health-related quality of life (HRQoL) and symptoms of constipation, and to assess the response of HRQoL

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer.

David A Johnson et al.

Gastrointestinal endoscopy, 80(4), 543-562 (2014-09-16)

Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer.